Volume 29, Issue 7 pp. 557-567
Research Article

Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY

Kendra Vehik

Corresponding Author

Kendra Vehik

Pediatrics Epidemiology Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

Correspondence to: Kendra Vehik, Pediatrics Epidemiology Center, Morsani College of Medicine, University of South Florida, 3650 Spectrum Blvd., STE 100, Tampa, FL 33612, USA.

E-mail: [email protected]

Search for more papers by this author
Steven W. Fiske

Steven W. Fiske

Pediatrics Epidemiology Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

Search for more papers by this author
Chad A. Logan

Chad A. Logan

Pediatrics Epidemiology Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

Search for more papers by this author
Daniel Agardh

Daniel Agardh

Department of Clinical Sciences, Malmo University Hospital, Lund University, Malmo, Sweden

Search for more papers by this author
Corrado M. Cilio

Corrado M. Cilio

Department of Clinical Sciences, Malmo University Hospital, Lund University, Malmo, Sweden

Search for more papers by this author
William Hagopian

William Hagopian

Pacific Northwest Diabetes Research Institute, Seattle, WA, USA

Search for more papers by this author
Olli Simell

Olli Simell

Department of Pediatrics, University of Turku, Turku, Finland

Search for more papers by this author
Merja Roivainen

Merja Roivainen

National Institute for Health and Welfare, Helsinki, Finland

Search for more papers by this author
Jin-Xiong She

Jin-Xiong She

Medical College of Georgia, Augusta, GA, USA

Search for more papers by this author
Thomas Briese

Thomas Briese

Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA

Search for more papers by this author
Sami Oikarinen

Sami Oikarinen

Department of Virology, Medical School, University of Tampere, Tampere, Finland

Search for more papers by this author
Heikki Hyoty

Heikki Hyoty

Department of Virology, Medical School, University of Tampere, Tampere, Finland

Department of Clinical Microbiology, Centre of Laboratory Medicine, Tampere University Hospital, Tampere, Finland

Search for more papers by this author
Anette-G. Ziegler

Anette-G. Ziegler

Institute of Diabetes Research, Helmholtz Zentrum München and Forschergruppe Diabetes e.V., Neuherberg, Germany

Search for more papers by this author
Marian Rewers

Marian Rewers

Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO, USA

Search for more papers by this author
Ake Lernmark

Ake Lernmark

Department of Clinical Sciences, Malmo University Hospital, Lund University, Malmo, Sweden

Search for more papers by this author
Beena Akolkar

Beena Akolkar

Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

Search for more papers by this author
Jeffrey P. Krischer

Jeffrey P. Krischer

Pediatrics Epidemiology Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

Search for more papers by this author
Brant R. Burkhardt

Brant R. Burkhardt

Pediatrics Epidemiology Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, FL, USA

Search for more papers by this author
The TEDDY Study Group
First published: 14 May 2013
Citations: 46

Abstract

Background

The vast array and quantity of longitudinal samples collected in The Environmental Determinants of Diabetes in the Young study present a series of challenges in terms of quality control procedures and data validity. To address this, pilot studies have been conducted to standardize and enhance both biospecimen collection and sample obtainment in terms of autoantibody collection, stool sample preservation, RNA, biomarker stability, metabolic biomarkers and T-cell viability.

Research Design and Methods

The Environmental Determinants of Diabetes in the Young is a multicentre, international prospective study (n = 8677) designed to identify environmental triggers of type 1 diabetes (T1D) in genetically at-risk children from ages 3 months until 15 years. The study is conducted through six primary clinical centres located in four countries.

Results

As of May 2012, over three million biological samples and 250 million total data points have been collected, which will be analysed to assess autoimmunity status, presence of inflammatory biomarkers, genetic factors, exposure to infectious agents, dietary biomarkers and other potentially important environmental exposures in relation to autoimmunity and progression to T1D.

Conclusions

Detailed procedures were utilized to standardize both data harmonization and management when handling a large quantity of longitudinal samples obtained from multiple locations. In addition, a description of the available specimens is provided that serve as an invaluable repository for the elucidation of determinants in T1D focusing on autoantibody concordance and harmonization, transglutaminase autoantibody, inflammatory biomarkers (T-cells), genetic proficiency testing, RNA lab internal quality control testing, infectious agents (monitoring cross-contamination, virus preservation and nasal swab collection validity) and HbA1c testing. Copyright © 2013 John Wiley & Sons, Ltd.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.